Merck & Co., Inc. (NEO:MRK)

Market Cap	290.35B
Revenue (ttm)	86.76B
Net Income (ttm)	22.38B
Shares Out	n/a
EPS (ttm)	8.84
PE Ratio	12.98
Forward PE	9.15
Dividend	n/a
Ex-Dividend Date	n/a

Volume	13,631
Average Volume	10,527
Open	18.85
Previous Close	18.88
Day's Range	18.78 - 18.94
52-Week Range	16.84 - 22.39
Beta	n/a
RSI	54.88
Earnings Date	Jul 29, 2025

About Merck & Co.

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The company offers human health pharmaceutical for various areas, including oncology, vaccines, hospital acute care, cardiovascular, virology, neuroscience, and diabetes under the Keytruda, Welireg, Gardasil, ProQuad, M−M−R II, Varivax, Vaxneuvance, RotaTeq, Pneumovax 23, Bridion, Dificid, Zerbaxa, Noxafil, Winrevair, Adempas, Verquvo, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janu...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1891
• Employees: 75,000
• Stock Exchange: Cboe Canada
• Ticker Symbol: MRK

Financial Performance

In 2024, Merck & Co.'s revenue was $64.17 billion, an increase of 6.74% compared to the previous year's $60.12 billion. Earnings were $17.12 billion, an increase of 4589.59%.

Financial numbers in USD